Melinda Telli, MD, on Triple-Negative Breast Cancer: New Clinical Approaches

2017 San Antonio Breast Cancer Symposium
Tweet this page

Melinda Telli, MD, of the Stanford University School of Medicine, discusses the current status of treatment for advanced TNBC, and new therapeutic strategies now being used for better outcomes.

Jul

Today In Oncology

American Cancer Society Outlines Blueprint for Cancer Control in the 21st Century

First-Line Treatment With Checkpoint Inhibitors in Patients With Melanoma Brain Metastases

Pazopanib Plus Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Somatic Driver Alterations and Distant Recurrence in Postmenopausal Early Breast Cancer Patients Receiving Endocrine Therapy

FDA Approves Enzalutamide for Castration-Resistant Prostate Cancer

;